HPV-specific immune response is suggested to play a role in the significantly better response to therapy of HPV-positive HNSCC patients. »
04/29/13

CUG2 enhances metastasis and drug resistance through STAT1 activation »
04/01/13

The purpose of this study was to investigate the clinical significance of DNA methylation of the human papillomavirus (HPV) genome as a prognostic biomarker for cervical intraepithelial neoplasia (CIN). »
01/15/13

Serum PLP levels and methionine intake might be inversely associated with breast cancer risk. »
05/02/13

Combination regimen may offer a particularly viable option »
08/08/13

Nrf2 is required to maintain the self-renewal of GSCs. »
08/10/13

Estrogen+progestin therapy results in a distinct molecular profile compared to estrogen-alone or tibolone therapy. »
08/12/13

Nrf2 is required to maintain the self-renewal of GSCs, and its down-regulation can attenuate the self-renewal of GSCs significantly. »
08/10/13

Pap smear screening of HPV-negative women more frequently than every 5 years could be harmful. »
08/09/13

Aim of this study was to determine the prevalence of oncogenic HPV in NPC »
08/12/13